In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.

The GLP‑1 Bridge pilot program would allow Medicare to broadly cover weight‑loss versions of GLP‑1 medications, such as ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the popular weight-loss drugs ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...